Forecast: Blood and Blood Forming Organs Medicine Use in France

In the forecast period from 2024 to 2028, the use of medicines for blood and blood-forming organs in France is projected to show a steady increase, with usage rising from 237.2 to 254.6 defined daily dosage units per thousand persons per day. Based on these forecasts, there is an anticipated year-on-year growth rate of approximately 1.8% to 1.9% throughout the period, suggesting consistent demand growth in this sector. The compound annual growth rate (CAGR) for the next five years stands at approximately 1.8%, highlighting a stable upward trend in the utilization of these medicines.

Future trends to watch for include:

• Shifts in healthcare policies or initiatives that could affect drug accessibility and affordability.
• Innovations and advancements in blood-related treatments and medications.
• Demographic changes, such as an aging population, that could impact demand for these medicines.
• Potential impacts of public health initiatives that focus on preventive care and lifestyle changes.